A Study of LY3041658 in Participants With Skin Diseases
The main purpose of this study is to investigate the safety and tolerability of the study drug known as LY3041658 in participants with certain types of skin diseases. The study will measure how the body absorbs, breaks down and gets rid of LY3041658.
The results of this study are not yet available.
Your participation could last approximately 10 weeks and include 8 visits to the study center
Here you can find out a bit more about the requirements for volunteers who took part in this study
- Participant must have diagnosis of skin diseases for at least 6 months as confirmed by the investigator
- Participant must have active skin lesions that are not responding to standard therapies
- Participant must be willing to undergo pre- and post-treatment skin biopsies of lesions
- Participant must not have other skin diseases that may interfere with evaluation of the specified skin disease being studied